Literature DB >> 25257250

EGFR signaling patterns are regulated by its different ligands.

Stine Louise Jeppe Knudsen1, Anni Sieu Wai Mac, Lasse Henriksen, Bo van Deurs, Lene Melsæther Grøvdal.   

Abstract

EGF receptor (EGFR) and its signaling have been investigated for many years, but how its different ligands regulate signaling has not been thoroughly explored. When investigating EGFR activation and downstream signaling in HeLa cells using a panel of ligands, we found a ligand-dependent differential activation of EGFR and the signaling pathways Akt, PLCγ and STAT with HB-EGF and BTC being the most potent ligands. All the tested ligands induced full activation of Erk signaling at 1 nM, whereas only HB-EGF and partly BTC and EGF induced strong activation of Akt, STAT3 and PLCγ at this concentration. Interestingly, we also found that the high activation potencies of HB-EGF and BTC could only partially be explained by their binding affinities, and are therefore likely to be regulated by other mechanisms. We thus suggest that the signaling pathways initiated from the EGFR vary depending on the ligands bound in a cell specific manner.

Entities:  

Keywords:  BTC; EGF; EGF receptor; HB-EGF; TGFα; signaling

Mesh:

Substances:

Year:  2014        PMID: 25257250     DOI: 10.3109/08977194.2014.952410

Source DB:  PubMed          Journal:  Growth Factors        ISSN: 0897-7194            Impact factor:   2.511


  28 in total

1.  Cytotoxicity of allitinib, an irreversible anti-EGFR agent, in a large panel of human cancer-derived cell lines: KRAS mutation status as a predictive biomarker.

Authors:  Renato José Silva-Oliveira; Viviane Aline Oliveira Silva; Olga Martinho; Adriana Cruvinel-Carloni; Matias Eliseo Melendez; Marcela Nunes Rosa; Flávia Escremim de Paula; Luciano de Souza Viana; André Lopes Carvalho; Rui Manuel Reis
Journal:  Cell Oncol (Dordr)       Date:  2016-02-26       Impact factor: 6.730

2.  Flotillin and AP2A1/2 Promote IGF-1 Receptor Association with Clathrin and Internalization in Primary Human Keratinocytes.

Authors:  Duncan Hieu M Dam; Sophia A Jelsma; Jeong Min Yu; Haoming Liu; Betty Kong; Amy S Paller
Journal:  J Invest Dermatol       Date:  2020-02-03       Impact factor: 8.551

3.  Serous carcinomatous component championed by heparin-binding EGF-like growth factor (HB-EGF) predisposing to metastasis and recurrence in stage I uterine malignant mixed mullerian tumor.

Authors:  Lei Zhang; David Shimizu; Jeffrey L Killeen; Stacey A Honda; Di Lu; Alexander Stanoyevitch; Fritz Lin; Beverly Wang; Edwin S Monuki; Michele Carbone
Journal:  Hum Pathol       Date:  2016-03-11       Impact factor: 3.466

4.  Different Epidermal Growth Factor Receptor (EGFR) Agonists Produce Unique Signatures for the Recruitment of Downstream Signaling Proteins.

Authors:  Tom Ronan; Jennifer L Macdonald-Obermann; Lorel Huelsmann; Nicholas J Bessman; Kristen M Naegle; Linda J Pike
Journal:  J Biol Chem       Date:  2016-01-19       Impact factor: 5.157

5.  MicroRNA-132 enhances transition from inflammation to proliferation during wound healing.

Authors:  Dongqing Li; Aoxue Wang; Xi Liu; Florian Meisgen; Jacob Grünler; Ileana R Botusan; Sampath Narayanan; Erdem Erikci; Xi Li; Lennart Blomqvist; Lei Du; Andor Pivarcsi; Enikö Sonkoly; Kamal Chowdhury; Sergiu-Bogdan Catrina; Mona Ståhle; Ning Xu Landén
Journal:  J Clin Invest       Date:  2015-06-29       Impact factor: 14.808

6.  Adult zebrafish intestine resection: a novel model of short bowel syndrome, adaptation, and intestinal stem cell regeneration.

Authors:  K A Schall; K A Holoyda; C N Grant; D E Levin; E R Torres; A Maxwell; H A Pollack; R A Moats; M R Frey; A Darehzereshki; D Al Alam; C Lien; T C Grikscheit
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2015-06-18       Impact factor: 4.052

7.  Cellular context alters EGF-induced ERK dynamics and reveals potential crosstalk with GDF-15.

Authors:  Harris B Krause; Alexis L Karls; Megan N McClean; Pamela K Kreeger
Journal:  Biomicrofluidics       Date:  2022-10-07       Impact factor: 3.258

Review 8.  Receptor tyrosine kinase activation: From the ligand perspective.

Authors:  Raphael Trenker; Natalia Jura
Journal:  Curr Opin Cell Biol       Date:  2020-02-27       Impact factor: 8.382

9.  EGFR Ligands Differentially Stabilize Receptor Dimers to Specify Signaling Kinetics.

Authors:  Daniel M Freed; Nicholas J Bessman; Anatoly Kiyatkin; Emanuel Salazar-Cavazos; Patrick O Byrne; Jason O Moore; Christopher C Valley; Kathryn M Ferguson; Daniel J Leahy; Diane S Lidke; Mark A Lemmon
Journal:  Cell       Date:  2017-10-05       Impact factor: 41.582

10.  Betacellulin (BTC) Biases the EGFR To Dimerize with ErbB3.

Authors:  Jamie S Rush; Joanne L Peterson; Brian P Ceresa
Journal:  Mol Pharmacol       Date:  2018-09-24       Impact factor: 4.436

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.